We are live on ! Find out more
SC

SummitTX Capital Portfolio holdings

AUM $3.2B
1-Year Est. Return 41.22%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+41.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.32B
AUM Growth
+$896M
Cap. Flow
+$807M
Cap. Flow %
24.32%
Top 10 Hldgs %
28.1%
Holding
1,021
New
296
Increased
249
Reduced
128
Closed
348

Top Sells

Rank Stock Value
1
TER icon
Teradyne
TER
+$24.9M
2
FYBR
Frontier Communications
FYBR
+$17.5M
3
CAT icon
Caterpillar
CAT
+$15.2M
4
DTE icon
DTE Energy
DTE
+$15M
5
FTI icon
TechnipFMC
FTI
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 13.67%
2 Industrials 13.31%
3 Healthcare 11.55%
4 Consumer Discretionary 6.78%
5 Real Estate 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTGX icon
201
Protagonist Therapeutics
PTGX
$8.55B
$3.69M 0.11%
42,266
+10,776
+34% +$882K
WT icon
202
WisdomTree
WT
$2.79B
$3.66M 0.11%
299,966
+237,170
+378% +$2.86M
TRV icon
203
Travelers Companies
TRV
$81.1B
$3.63M 0.11%
12,512
+8,618
+221% +$2.43M
DNTH icon
204
Dianthus Therapeutics
DNTH
$5.69B
$3.62M 0.11%
+87,926
New +$3.41M
AGNC icon
205
AGNC Investment
AGNC
$12.7B
$3.59M 0.11%
335,253
+9,263
+3% +$95.2K
CCJ icon
206
Cameco
CCJ
$36.8B
$3.59M 0.11%
+39,253
New +$3.53M
AVTX icon
207
Avalo Therapeutics
AVTX
$1.01B
$3.56M 0.11%
+195,873
New +$3.31M
HOG icon
208
Harley-Davidson
HOG
$2.61B
$3.53M 0.11%
+172,300
New +$4.24M
ORI icon
209
Old Republic International
ORI
$10.9B
$3.51M 0.11%
77,001
+58,092
+307% +$2.52M
PH icon
210
Parker-Hannifin
PH
$120B
$3.51M 0.11%
+3,993
New +$3.27M
CHH icon
211
Choice Hotels
CHH
$5.26B
$3.43M 0.1%
36,026
+5,953
+20% +$567K
GKOS icon
212
Glaukos
GKOS
$9.49B
$3.33M 0.1%
29,534
+13,476
+84% +$1.29M
AWK icon
213
American Water Works
AWK
$27B
$3.32M 0.1%
+25,471
New +$3.4M
WSO icon
214
Watsco Inc
WSO
$13.2B
$3.29M 0.1%
9,756
-1,065
-10% -$380K
FIVE icon
215
Five Below
FIVE
$11.6B
$3.28M 0.1%
17,418
+14,617
+522% +$2.38M
EXAS
216
CALL
DELISTED
Exact Sciences
EXAS
$3.28M 0.1%
+32,300
New +$2.59M
VRTX icon
217
Vertex Pharmaceuticals
VRTX
$123B
$3.28M 0.1%
7,231
-724
-9% -$312K
WEN icon
218
Wendy's
WEN
$1.46B
$3.27M 0.1%
392,948
+129,970
+49% +$1.12M
HUBS icon
219
HubSpot
HUBS
$12.9B
$3.26M 0.1%
8,132
+6,575
+422% +$2.72M
AU icon
220
AngloGold Ashanti
AU
$39.4B
$3.25M 0.1%
+38,155
New +$2.98M
USB icon
221
US Bancorp
USB
$97.9B
$3.23M 0.1%
+60,520
New +$2.98M
ACI icon
222
Albertsons Companies
ACI
$5.85B
$3.22M 0.1%
187,349
+154,647
+473% +$2.76M
FTV icon
223
Fortive
FTV
$18B
$3.2M 0.1%
+57,937
New +$3.01M
DRI icon
224
Darden Restaurants
DRI
$24.3B
$3.2M 0.1%
+17,373
New +$3.17M
LECO icon
225
Lincoln Electric
LECO
$14.1B
$3.18M 0.1%
13,276
+7,817
+143% +$1.85M

Similar funds

SummitTX Capital's Q4 2025 Portfolio in Review

As of Q4 2025, SummitTX Capital held 1,021 positions worth $3.32B, up 37% from $2.42B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

SummitTX Capital deployed $807M of net new capital in Q4 2025, opening 296 new positions and adding to 249 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 299,442 shares worth $57.4M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 17% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Teradyne, an estimated $24.9M trimmed.

  • SummitTX Capital's largest Q4 2025 buy was Invesco S&P 500 Equal Weight ETF: 299,442 shares worth $57.4M.
  • SummitTX Capital added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $185M increase.
  • SummitTX Capital's biggest Q4 2025 reduction was Teradyne, cutting an estimated $24.9M.
  • SummitTX Capital fully exited Caterpillar in Q4 2025, selling an estimated $15.2M.
  • SummitTX Capital's ten largest holdings make up 28% of its $3.32B portfolio in Q4 2025.
  • SummitTX Capital opened 296 new positions and closed 348 in Q4 2025.
  • SummitTX Capital's portfolio value rose 37% quarter-over-quarter to $3.32B.

Based on SummitTX Capital's 13F filing for Q4 2025, filed 17 Feb 2026.